An aromatase inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Aminoglutethimide

Item No. 20947

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
3-(4-aminophenyl)-3-ethyl-2,6-piperidinedione
CAS Number
125-84-8
Synonyms
  • DL-Aminoglutethimide
  • NSC 330915
Molecular Formula
C13H16N2O2
Formula Weight
232.3
Purity
≥98%
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 10 mg/mlDMSO: 10 mg/mlDMSO:PBS (pH 7.2) (1:1): 0.5 mg/mlEthanol: 10 mg/ml
λmax
242 nm
SMILES
O=C1NC(C(C2=CC=C(N)C=C2)(CC)CC1)=O
InChi Code
InChI=1S/C13H16N2O2/c1-2-13(8-7-11(16)15-12(13)17)9-3-5-10(14)6-4-9/h3-6H,2,7-8,14H2,1H3,(H,15,16,17)
InChi Key
ROBVIMPUHSLWNV-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 g

    $36

    Add

    5 g

    $103

    Add

    10 g

    $186

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Aminoglutethimide is an aromatase inhibitor (IC50 = 7.5 µM).1 Aromatase inhibitors, including aminoglutethimide, inhibit estrogen synthesis via aromatase, suppressing estrogen levels in post-menopausal women. Formulations containing aromatase inhibitors have been used to treat estrogen receptor-positive breast cancer in post-menopausal women.2,3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Campbell, D.R., and Kurzer, M.S. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J. Steroid Biochem. Mol. Biol. 46(3), 381-388 (1993).

    2. Santen, R.J., and Harvey, H.A. Use of aromatase inhibitors in breast carcinoma. Endocr. Relat. Cancer 6, 75-92 (1999).

    3. Smith, I.E., and Dowsett, M. Aromatase inhibitors in breast cancer. N. Engl. J. Med. 348(24), 2431-2442 (2003).